Some Multiple sclerosis patients receiving recombinant interferonbeta (IFNb) develop IFNbspecific antibodies that may block the therapeutic effect of the treatment. This assay screens for IgG antibodies capable of binding to IFNb.
Sample Type - Blood
Reporting Time - Please Call Customer care
Prerequisites - No special preparation required
Price - ₹18640/-
Add to cart Go Home